New publication in Journal of Pediatric Pharmacology and Therapeutics entitled, "Clopidogrel Dosing Scheme in Pediatric Cardiac Patients 0-24 Months Old Using P2Y12 Reaction Unit Monitoring". In short, this paper provides dosing guidelines for the use of Clopidogrel in children 0-24 months. This guideline will likely become a landmark study that will be utilized by pediatric providers across the US and is likely to be referenced in medication databases such as Lexicomp.